Farallon Capital Management’s Acceleron Pharma Inc. XLRN Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,164,663	Closed	-$373M	–	339
2021 Q3	$373M	Sell	2,164,663 -335,337	-13%	-$57.7M	1.74%	14
2021 Q2	$314M	Sell	2,500,000 -100,000	-4%	-$12.5M	1.28%	24
2021 Q1	$353M	Hold	2,600,000	–	–	1.75%	17
2020 Q4	$333M	Hold	2,600,000	–	–	2%	18
2020 Q3	$293M	Buy	2,600,000 +500,000	+24%	+$56.3M	2.02%	19
2020 Q2	$200M	Sell	2,100,000 -75,000	-3%	-$7.15M	1.6%	22
2020 Q1	$195M	Buy	2,175,000 +175,000	+9%	+$15.7M	1.68%	20
2019 Q4	$106M	Sell	2,000,000 -400,000	-17%	-$21.2M	0.72%	34
2019 Q3	$94.8M	Buy	2,400,000 +25,000	+1%	+$988K	0.72%	34
2019 Q2	$97.6M	Hold	2,375,000	–	–	0.63%	34
2019 Q1	$111M	Buy	2,375,000 +275,000	+13%	+$12.8M	0.83%	32
2018 Q4	$91.5M	Buy	2,100,000 +259,268	+14%	+$11.3M	0.67%	33
2018 Q3	$105M	Buy	1,840,732 +439,732	+31%	+$25.2M	0.62%	32
2018 Q2	$68M	Hold	1,401,000	–	–	0.42%	43
2018 Q1	$54.8M	Buy	1,401,000 +313,000	+29%	+$12.2M	0.38%	44
2017 Q4	$46.2M	Buy	1,088,000 +125,000	+13%	+$5.31M	0.38%	42
2017 Q3	$35.9M	Buy	+963,000	New	+$35.9M	0.32%	47